[en] Radiolabelled ganciclovir analogues have shown promise as imaging agents to detect herpes simplex virus thymidine kinase (HSVtk) expression. This study evaluated the use of positron emission tomography (PET) imaging with 9-[(3-[18F]fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]FHPG) to assess gene transfer into tumours. HSVtk-positive and HSVtk-negative cell lines were first treated in vitro with [18F]FHPG. To assess the efficacy of PET in detecting HSVtk expression following in vivo gene transfer, mice were injected intravenously with an adenovirus encoding HSVtk (Ad.HSVtk), a control vector (Ad.Bgl2) or saline. Subcutaneous human glioma xenografts were grown in mice and treated by direct injection of Ad.HSVtk or Ad.Bgl2. Imaging was performed 48 h after transduction. Similar experiments were performed using Fischer rats implanted with syngeneic tumours. The presence of the HSVtk protein was confirmed by immunohistochemistry. Biodistribution studies were also obtained in 14 naive mice. In vitro studies showed high and specific uptake of [18F]FHPG in HSVtk-positive cell lines, with an uptake ratio of up to 27:1. PET imaging and direct counting of major organs demonstrated HSVtk-specific tracer retention. In mice, HSVtk-positive tumours retained 3.4% dose/gram as compared to 0.6% for control tumours (P=0.03). They were clearly seen on the PET images as early as 100 min post injection. Similar results were obtained with syngeneic rat tumours. Biodistribution studies demonstrated the rapid distribution and clearance of the tracer in all major organs. Our results demonstrate that PET imaging of HSVtk gene transfer to tumours is feasible and is highly specific for HSVtk expression.
Disciplines :
Radiology, nuclear medicine & imaging
Author, co-author :
Hustinx, Roland ; Université de Liège - ULiège > Département des sciences cliniques > Médecine nucléaire
Shiue, C. Y.
Alavi, A.
McDonald, D.
Shiue, G. G.
Zhuang, H.
Lanuti, M.
Lambright, E.
Karp, J. S.
Eck, S. L.
Language :
English
Title :
Imaging in Vivo Herpes Simplex Virus Thymidine Kinase Gene Transfer to Tumour-Bearing Rodents Using Positron Emission Tomography And
Pauwels E.K., Ribeiro M.J., Stoot J.H. (1998) FDG accumulation and tumor biology. Nucl Med Biol 25:317-322.
Eary J.F., Mankoff D.A., Spence A.M. (1999) 2-[C-11]thymidine imaging of malignant brain tumors. Cancer Res 59:615-621.
Rigo P., Paulus P., Kaschten B.J. (1996) Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 23:1641-1674.
Hustinx R., Eck S.L., Alavi A. (1999) Potential applications of PET imaging in developing novel cancer therapies. J Nucl Med 40:995-1002.
Dranoff G. (1998) Cancer gene therapy: Connecting basic research with clinical inquiry. J Clin Oncol 16:2548-2556.
Monclus M., Luxen A., Cool V. (1997) Development of a positron emission tomography radiopharmaceutical for imaging thymidine kinase gene expression: Synthesis and in vitro evaluation of 9-((3-(18F)fluoro-1-hydroxy-2-propoxy)methyl)guanine. Bioorg Med Chem Lett 7:1879-1882.
Tjuvajev J.G., Finn R., Watanabe K. (1996) Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: A potential method for monitoring clinical gene therapy. Cancer Res 56:4087-4095.
Barrio J.R., Namavari M., Srinivasan A. (1997) Carbon-8 radiofluorination of purines: A general approach to probe design for gene therapy in humans. J Labelled Compd Radipharm 40:348.
Tjuvajev J.G., Avril N., Oku T. (1998) Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 58:4333-4341.
Gambhir S.S., Barrio J.R., Phelps M.E. (1999) Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci USA 96:2333-2338.
Hospers G.A., Calogero A., Van Waarde A. (2000) Monitoring of herpes simplex virus thymidine kinase enzyme activity using positron emission tomography. Cancer Res 60:1488-1491.
Alauddin M.M., Conti P.S., Mazza S.M. (1996) 9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): A potential imaging agent of viral infection and gene therapy using PET. Nucl Med Biol 23:787-792.
Shiue G.G., Shiue C.Y., Lee R.L. (2000) A simplified one-pot synthesis of 9-[(3-[18F]fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]FHPG) and 9-(4-[18F]fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG) for gene therapy. Nucl Med Biol, in press; .
Smith J.G., Raper S.E., Wheeldon E.B. (1997) Intracranial administration of adenovirus expressing HSV-TK in combination with ganciclovir produces a dose-dependent, self-limiting inflammatory response. Hum Gene Ther 8:943-954.
Smith J.G., Eck S.L. (1999) Molecular characterization of an adenoviral vector resulting from both homologous and nonhomologous recombination. Cancer Gene Ther 6:475-481.
Sterman D.H., Treat J., Litzky L.A. (1998) Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: Results of a phase I clinical trial in malignant mesothelioma. Hum Gene Ther 9:1083-1092.
Karp J.S., Freifelder R., Geagan M.J. (1997) Three-dimensional imaging characteristics of the HEAD PENN-PET scanner. J Nucl Med 38:636-643.
Moolten F.L., Wells J.M., Heyman R.A. (1990) Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum Gene Ther 1:125-134.
Moolten F.L., Wells J.M. (1990) Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 82:297-300.
Alavi J.B., Eck S.L. (1998) Gene therapy for malignant gliomas. Hematol Oncol Clin North Am 12:617-629.
Ram Z., Culver K.W., Oshiro E.M. (1997) Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med 3:1354-1361.
Tjuvajev J.G., Stockhammer G., Desai R. (1995) Imaging the expression of transfected genes in vivo. Cancer Res 55:6126-6132.
Morin K.W., Knaus E.E., Wiebe L.I. (1997) Non-invasive scintigraphic monitoring of gene expression in a HSV-1 thymidine kinase gene therapy model. Nucl Med Commun 18:599-605.
Germann C., Shields A.F., Grierson J.R. (1998) 5-Fluoro-1-(2′-deoxy-2′-fluoro-beta-D-ribofuranosyl) uracil trapping in Morris hepatoma cells expressing the herpes simplex virus thymidine kinase gene. J Nucl Med 39:1418-1423.
Tjuvajev J.G., Chen S.H., Joshi A. (1999) Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res 59:5186-5193.
Pentlow K.S., Graham M.C., Lambrecht R.M. (1996) Quantitative imaging of iodine-124 with PET. J Nucl Med 37:1557-1562.
Haberkorn U., Altmann A., Morr I. (1997) Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: Uptake of specific substrates. J Nucl Med 38:287-294.
Haberkorn U., Khazaie K., Morr I. (1998) Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase. Nucl Med Biol 25:367-373.
Gambhir S.S., Barrio J.R., Wu L. (1998) Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med 39:2003-2011.
Monclus M., Luxen A., Cool V. (1997) Synthesis of (R)- and (S)-9-((3-(18F)fluoro-1-hydroxy-2-propoxy)methyl)guanine: Radiopharmaceuticals for gene therapy. J Labelled Compd Radiopharm 40:20-22.
Alauddin M.M., Shahinian A., Kundu R.K. (1999) Evaluation of 9-[(3-18F-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors. Nucl Med Biol 26:371-376.
Bading J.R., Alauddin M.M., Fissekis J.H. (1997) Pharmacokinetics of F-18 fluorohydroxy-propoxymethylguanine (FHPG) in primates. J Nucl Med 38:43P.
Gambhir S.S., Bauer E., Black M.E. (2000) A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci USA 97:2785-2790.
Green L.A., Gambhir S.S., Barrio J.R. (1998) Tracer kinetic modeling of 8-(F-18)-fluoroganciclovir PET data: A new tracer for measuring reporter gene expression. J Nucl Med 39:10P.
Zasadny K.R., Wahl R.L. (1993) Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: Variations with body weight and a method for correction. Radiology 189:847-850.
